Narum v. Eli Lilly and Co.

914 F. Supp. 317, 1996 U.S. Dist. LEXIS 1552, 1996 WL 54500
CourtDistrict Court, D. Minnesota
DecidedJanuary 26, 1996
DocketCiv. 3-94-1185
StatusPublished
Cited by4 cases

This text of 914 F. Supp. 317 (Narum v. Eli Lilly and Co.) is published on Counsel Stack Legal Research, covering District Court, D. Minnesota primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Narum v. Eli Lilly and Co., 914 F. Supp. 317, 1996 U.S. Dist. LEXIS 1552, 1996 WL 54500 (mnd 1996).

Opinion

MEMORANDUM AND ORDER

MAGNUSON, Chief Judge.

This matter is before the Court upon the various motions of Eli Lilly and Company. Eli Lilly moves the Court to strike the Affidavit of Linda Borer and the Affidavit of Plaintiff Mary Jo Hadler Narum, as well as to grant summary judgment in Eli Lilly’s favor.

BACKGROUND

According to Ms. Narum, in 1956 or 1957 Narum’s mother, while she was pregnant with Narum, ingested a drug that was manufactured and sold by Eli Lilly. The drug was “diethylstilbestrol” (DES). In 1975 Narum became aware that her mother had ingested DES and she obtained literature concerning DES. Narum learned from the literature that, because of her exposure to DES, she had an increased risk of developing cancer of the vagina or cervix, that she may have difficulties becoming pregnant or carrying a pregnancy to term, and that she might develop structural changes in her vagina and cervix. Because of the increased risk of contracting cancer, the literature warned that females who were exposed to DES should be examined regularly.

In 1980, Narum underwent a colposcopy, a diagnostic test which revealed she had no cervical or vaginal cancer. Narum became pregnant in early 1985. Dr. McCollum diagnosed Narum as having a cervical hood. Na-rum testified during her deposition that Dr. McCollum advised her she had the cervical hood and told her she had “classic DES exposure cervix.” On March 15, 1985, Dr. McCollum noted in his medical report that Narum “does have a [history] of DES induced changes.” Narum recalls being informed her cervical hood was caused by her DES exposure. In April 1985, Narum lost her baby to a miscarriage. She attributes the miscarriage to her exposure to DES.

In October 1989, Dr. McCollum referred Narum to Dr. Ahrens. Dr. Ahrens noted on Narum’s record, “DES exposure," and also noted “a history of in útero DES exposure referred to by Dr. McCollum for further evaluation.” Dr. Ahrens also noted in his October 1989 report that Narum’s cervix “had a wide transformation zone and cervical hood as expected with DES exposure.... The most abnormal area [of the vaginal forn-ices] was biopsied.” Narum recalls being referred to Dr. Ahrens at that time because of DES exposure and because of abnormal growths that Dr. Ahrens removed from Na-rum’s vagina or cervix. Narum testified that Dr. Ahrens also informed her that her “cervix was typical DES.”

*319 Narum married in 1990. She and her husband attempted to conceive a child beginning in July 1991. Unsuccessful, she consulted with Dr. Ahrens. Dr. Ahrens ultimately performed a hysterosalpingography. This test revealed Narum had an abnormally shaped uterus; specifically, the uterus was “T shaped”. Dr. Ahrens reported the test results to Narum April 22, 1992. Eli Lilly asserted at oral argument, without contradiction by Narum, that Narum had her abnormal, T-shaped uterus since birth. Neither Narum nor Dr. Ahrens was aware she had a T-shaped uterus until April 1992. In August 1992, a physician informed Narum her T-shaped uterus would prohibit her from having a child.

Narum filed this action on August 11,1994. In it she accuses Eli Lilly of negligence, strict liability, breach of warranty, misrepresentation, and fraudulent concealment. In part, Narum’s Complaint states:

As a direct and proximate cause of the Defendant’s negligence, strict liability[,] breach of warranty, misrepresentation, and fraudulent concealment, the Plaintiff was exposed to dosages of DES or DES-related compounds or congeners before birth which caused her to suffer infertility, to contract vaginal adenosis, and to be threatened with the development of cancerous growths and other abnormal cellular changes; to be cause to seek medical care and attention for said conditions; to suffer severe and continuing personal injury and mental anguish, and[] to expend monies for medical care and attention, as well as additional monies and costs [assorted with the adoption of children as a direct and proximate result of infertility.

Compl. ¶ 37. Eli Lilly moves the Court to grant summary judgment, arguing that all of Narum’s claims are barred by the statute of limitations. The Court will discuss other facts as they become relevant.

DISCUSSION

Summary judgment is appropriate if there is no genuine issue of material fact and the moving party is entitled to judgment as a matter of law. Fed.R.Civ.P. 56(c); Celotex Corp. v. Catrett, 477 U.S. 317, 106 S.Ct. 2548, 91 L.Ed.2d 265 (1986); Unigroup, Inc. v. O’Rourke Storage & Transfer Co., 980 F.2d 1217, 1219-20 (8th Cir.1992). The court determines materiality from the substantive law governing the claim. Anderson v. Liberty Lobby, Inc., 477 U.S. 242, 248, 106 S.Ct. 2505, 2510, 91 L.Ed.2d 202 (1986). Disputes over facts that might affect the outcome of the lawsuit according to applicable substantive law are material. Id. A material fact dispute is “genuine” if the evidence is sufficient to allow a reasonable jury to return a verdict for the non-moving party. Id. at 248-49, 106 S.Ct. at 2510-11.

Both parties agree to the various applicable statutes of limitations in this case, the longest of which permits six years to file a claim. Minn.Stat. § 541.05. The parties also agree that the standard that Minnesota law requires the Court to apply is found in Hildebrandt v. Allied Corp.; that is, two elements must be satisfied before a cause of action accrues: “(1) a cognizable physical manifestation of the disease or injury, and (2) evidence of a causal connection between the injury or disease and the defendant’s product, act, or omission.” 839 F.2d 396, 398 (8th Cir.1987).

Eli Lilly argues that long ago Narum became aware of various “injuries” resulting from her mother’s DES ingestion, and is barred by the various statutes of limitations. In response, Narum argues that the early conditions to which Eli Lilly refers (such as the 1985 miscarriage, vaginal adenosis, threat or fear of cancer) were not “injuries” that could sustain a claim for damages, thus the limitations clock did not begin running until she learned of her T-shaped uterus in 1992. On its face, Narum’s argument is plausible. However, her Complaint and her own testimony negates the argument.

The Complaint lists vaginal adenosis and threat of cancer development as injuries directly caused by her DES exposure, and in her deposition testimony she also includes her 1985 miscarriage, her fear of cancer and her need for frequent colposcopy exams and biopsies as injuries caused by her DES exposure. She seeks damages for all of these (except the miscarriage) in her Complaint. Thus, her argument that she had no compen- *320

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Green v. A.P.C.
960 P.2d 912 (Washington Supreme Court, 1998)
Green v. APC (Am. Pharmaceutical Co.)
960 P.2d 912 (Washington Supreme Court, 1998)
Strand v. General Electric Co.
945 F. Supp. 1334 (D. Hawaii, 1996)

Cite This Page — Counsel Stack

Bluebook (online)
914 F. Supp. 317, 1996 U.S. Dist. LEXIS 1552, 1996 WL 54500, Counsel Stack Legal Research, https://law.counselstack.com/opinion/narum-v-eli-lilly-and-co-mnd-1996.